Cosmetic Science Biotech Co., Ltd. (1786) Announces Q4 2025 Financial Results
Key facts
- Cosmetic Science Biotech Co., Ltd. (1786) Announces Q4 2025 Financial Results
- Cosmetic Science Biotech Co., Ltd. (1786) reported its operating results for the fourth quarter of 2025. The company announced a basic earnings per share (EPS) of NT$2.24 for the quarter. Revenue reached NT$887 million, with a net profit after tax of NT$162 million. Cosmetic Science Biotech operates within the biotechnology and medical industry.
- Source: PR Times
- Date: December 1, 2025
Direct answer
Cosmetic Science Biotech Co., Ltd. (1786) reported its operating results for the fourth quarter of 2025. The company announced a basic earnings per share (EPS) of NT$2.24 for the quarter. Revenue reached NT$887 million, with a net profit after tax of NT$162 million. Cosmetic Science Biotech operates within the biotechnology and medical industry.
- Citation
- Cosmetic Science Biotech Co., Ltd. (1786) Announces Q4 2025 Financial Results (December 1, 2025), PR Times
- Source
- PR Times
- Date
- December 1, 2025
Cosmetic Science Biotech Co., Ltd. (1786) reported its operating results for the fourth quarter of 2025. The company announced a basic earnings per share (EPS) of NT$2.24 for the quarter. Revenue reached NT$887 million, with a net profit after tax of NT$162 million. Cosmetic Science Biotech operates within the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 1786
Company Name: Cosmetic Science Biotech Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.24
Operating Revenue: NT$887 million
Net Profit After Tax: NT$162 million
Company Name: Cosmetic Science Biotech Co., Ltd.
Industry: Biotechnology and Medical
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.24
Operating Revenue: NT$887 million
Net Profit After Tax: NT$162 million
FAQ
What were Cosmetic Science Biotech's Q4 2025 earnings per share?
Cosmetic Science Biotech's basic earnings per share for Q4 2025 was NT$2.24.
What was the company's revenue in the fourth quarter of 2025?
The company's operating revenue for Q4 2025 was NT$887 million.
What was the net profit after tax for Cosmetic Science Biotech in Q4 2025?
The net profit after tax for Q4 2025 was NT$162 million.